Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion type Assertion NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_head.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion description "[The data provide further evidence that targeted inhibition of MEK may be therapeutically effective for thyroid cancer, particularly if the PI3K and NF-kappaB pathways are concurrently inhibited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_provenance.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion evidence source_evidence_literature NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_provenance.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion SIO_000772 18651802 NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_provenance.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion wasDerivedFrom befree-20150227 NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_provenance.
- NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_assertion wasGeneratedBy ECO_0000203 NP646184.RA19AEN8PxieyT2mUmQopVugFLakLahob1rJVN6PZbOx8130_provenance.